c-LEcta
AcquiredHome | c-LEcta GmbH | Kerry Biotechnology Centre
Leipzig, Germany · Founded 2004
- Headquarters
- Leipzig
- Employees
- 51–200
- Founded
- 2004
- Business Model
- B2B
- Website
- c-lecta.com
About
c-LEcta is a global industrial biotechnology company founded in 2004 as a spin-off from the University of Leipzig, specializing in the development, production, and distribution of customized enzyme products and microbial strains. Using its proprietary ENESYZ technology platform — a bioinformatics-based system for targeted enzyme engineering — c-LEcta serves pharmaceutical, food, and industrial customers worldwide. The company maintains a collection of over 5,000 preselected microbial strains and million-gene metagenomic libraries to identify and engineer best-in-class biocatalysts. In 2022, c-LEcta was acquired by Kerry Group for €137 million and now operates as a Kerry Biotechnology Centre in Leipzig.
Summary
c-LEcta is a Biotech company based in Leipzig, Germany, founded in 2004.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Exit History
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/c-lecta"><img src="https://indexed.vc/api/badge/company/c-lecta" alt="c-LEcta on Indexed.vc" width="260" height="76" /></a>